Quick summary

Ginger (Zingiber officinale) is a widely used medicinal and culinary plant with evidence suggesting potential anti-inflammatory, antioxidant, antidiabetic, antiemetic, and lipid-modulating effects. Clinical studies from randomized controlled trials and meta-analyses indicate ginger supplementation may improve markers related to cardiovascular health, metabolic control in type 2 diabetes, and reduce nausea and vomiting associated with pregnancy and chemotherapy. However, clinical evidence is often heterogeneous, with variable study quality and dosing, and further research is needed to confirm efficacy, safety, optimal dosing, and long-term outcomes.

What is it

Ginger is the rhizome of the Zingiber officinale plant, commonly used as a spice and traditional herbal remedy. It contains several bioactive compounds and has a long history of use for digestive and inflammatory conditions in various traditional medicine systems.

Traditional uses

Traditionally, ginger has been employed to help alleviate digestive issues such as nausea, indigestion, and motion sickness. It has also been used for inflammatory conditions and to support overall wellness. In many cultures, ginger is used to relieve menstrual pain, muscle soreness, and respiratory ailments.

Active compounds

Key active constituents of ginger include gingerols, shogaols, paradols, and zingerone. These compounds are believed to contribute to its anti-inflammatory, antioxidant, and digestive effects. Multiple bioactives act via various biochemical pathways, which are the focus of current research.

Potential benefits with evidence levels

  • Anti-inflammatory and antioxidant effects (Moderate evidence)
    Systematic reviews and meta-analyses of randomized controlled trials (RCTs) show ginger supplementation may reduce inflammatory markers such as CRP, TNF-α, IL-6 and improve antioxidant biomarkers like total antioxidant capacity and superoxide dismutase. However, results vary due to study heterogeneity.
  • Glycemic control in type 2 diabetes (Moderate evidence)
    Meta-analyses suggest ginger supplementation may lower fasting blood glucose, HbA1c, insulin levels, and improve insulin resistance indices in patients with type 2 diabetes. Study quality and designs vary.
  • Cardiovascular health improvement (Moderate evidence)
    Evidence from RCT systematic reviews indicates ginger supplementation may improve cardiovascular biomarkers such as blood pressure and lipid profiles, including reductions in triglycerides and LDL cholesterol, along with increased HDL cholesterol. More research is needed on proper dosing.
  • Reduction of nausea and vomiting in pregnancy and chemotherapy (Moderate evidence)
    Reviews of clinical trials show ginger may reduce nausea severity related to pregnancy and chemotherapy-induced nausea and vomiting (CINV) in adults and children. Ginger was generally well-tolerated.
  • Weight and body fat reduction (Low to moderate evidence)
    Some RCTs indicate ginger may decrease body fat percentage and waist circumference and improve adipokine profiles, although effects on overall body weight and BMI are inconsistent. Longer studies are needed.
  • Pain relief in dental pain and dysmenorrhea (Low to moderate evidence)
    Limited data suggest ginger may provide analgesic effects in dental pain and primary dysmenorrhea, potentially comparable to standard treatments, but further high-quality trials are required.
  • Anti-diabetic enzyme regulation and metabolic syndrome (Preliminary / insufficient evidence)
    Some early studies suggest ginger may regulate carbohydrate metabolism enzymes and improve aspects of metabolic syndrome; however, clinical evidence is preliminary and needs further validation.

Side effects

Ginger supplementation is generally well-tolerated. Mild gastrointestinal symptoms such as belching, heartburn, or mild nausea are the most commonly reported side effects. No severe adverse events or liver toxicity have been consistently reported in clinical trials. Some theoretical bleeding risk exists due to antiplatelet properties, though clinical evidence is limited.

Drug interactions

Limited clinical data exist regarding interactions between ginger and medications. Preclinical findings suggest possible interactions through cytochrome P450 enzyme modulation and antiplatelet effects, which may influence the efficacy or safety of anticoagulant or antithrombotic drugs. Clinical significance is unclear, so careful monitoring is advised when ginger is used alongside such medications.

Who should avoid it

While no absolute contraindications have been well documented, caution is recommended for individuals with bleeding disorders or those taking anticoagulant or antiplatelet therapies due to limited safety data. Although evidence suggests ginger is generally safe during pregnancy for nausea, use should still be supervised by a healthcare provider. Data on safety during breastfeeding are lacking.

Evidence limitations

Many clinical studies on ginger exhibit high heterogeneity in dosing, formulations, treatment duration, and participant populations. Often, trials have small sample sizes, inconsistent quality, and relatively short follow-up. Lack of standardization in ginger preparations and incomplete reporting of adverse events further limits definitive conclusions. Large-scale, high-quality randomized controlled trials using standardized extracts are needed to confirm efficacy, determine optimal dosing, and establish long-term safety.

References

Last reviewed

June 2024

Informational disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new supplement, especially if you have underlying health conditions or are taking medications.